Fagron N.V. buy melinda
Start price
06.02.18
/
50%
€10.02
Target price
07.02.18
€11.40
Performance (%)
16.17%
End price
07.02.18
€11.64
Summary
This prediction ended on 07.02.18 with a price of €11.64. The prediction had a final performance of 16.17%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fagron N.V. | -3.750% | -3.750% | 2.212% | 43.211% |
| iShares Core DAX® | -0.464% | -0.827% | 0.518% | 50.561% |
| iShares Nasdaq 100 | -1.413% | -3.024% | 27.534% | 82.266% |
| iShares Nikkei 225® | -1.246% | -7.626% | 45.082% | 68.202% |
| iShares S&P 500 | -1.147% | 0.585% | 21.655% | 64.994% |
Comments by melinda for this prediction
In the thread Fagron N.V. diskutieren
Pharmazeutische SecteurProduits Agenda 07/02 Ergebnisse Veröffentlichung
Die geographische Verteilung des Umsatzes sieht wie folgt aus: Belgien (8%), Europa (51,5%), Lateinamerika (21,6%), USA (18,1%) und sonstiges (0,8%).
Anzahl der Mitarbeiter: 1.991 Personen.